APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Imaging Software

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cancer Imaging Software Market Analysis and Forecast 2026-2032

Report ID 174534930512 August 2026170 pages

Choose your research edition.

Industry ResearchCancer Imaging Software Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Imaging Software Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Cancer Imaging Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Imaging Software Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Imaging Software Market Analysis and Forecast 2026-2032170 pages · $4,950 USD

Market perspective

The global Cancer Imaging Software market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cancer Imaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cancer Imaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cancer Imaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cancer Imaging Software is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cancer Imaging Software include Imaris, Varian, DOSIsoft, Certis Oncology, MIM Software Inc., Arterys, SIEMENS, Brainomix and Oncology Systems Limited, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cancer Imaging Software, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cancer Imaging Software, also provides the revenue of main regions and countries. Of the upcoming market potential for Cancer Imaging Software, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cancer Imaging Software revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cancer Imaging Software market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cancer Imaging Software revenue, projected growth trends, production technology, application and end-user industry.

Cancer Imaging Software Segment by Company

Imaris

Varian

DOSIsoft

Certis Oncology

MIM Software Inc.

Arterys

SIEMENS

Brainomix

Oncology Systems Limited

Mirada

GE HealthCare

Mint Medical

Cancer Imaging Software Segment by Type

CT

MRI

MRA

Others

Cancer Imaging Software Segment by Application

Clinical Routine

Clinical Trials

Cancer Imaging Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Imaging Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Imaging Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Imaging Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cancer Imaging Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cancer Imaging Software company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cancer Imaging Software revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cancer Imaging Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CT Major Player Table 3. MRI Major Player Table 4. MRA Major Player Table 5. Others Major Player Table 6. Global Cancer Imaging Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Clinical Routine Major Player Table 8. Clinical Trials Major Player Table 9. Cancer Imaging Software Industry Trends Table 10. Cancer Imaging Software Industry Drivers Table 11. Cancer Imaging Software Industry Opportunities and Challenges Table 12. Cancer Imaging Software Industry Restraints Table 13. Global Cancer Imaging Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cancer Imaging Software Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cancer Imaging Software Market Share by Region (2021-2026) Table 16. Global Cancer Imaging Software Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cancer Imaging Software Market Share by Region (2027-2032) Table 18. Global Cancer Imaging Software Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cancer Imaging Software Revenue Market Share by Players (2021-2026) Table 20. Global Cancer Imaging Software Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cancer Imaging Software Key Players Headquarters & Area Served Table 22. Global Cancer Imaging Software Players, Product Type & Application Table 23. Global Cancer Imaging Software Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cancer Imaging Software by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cancer Imaging Software Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cancer Imaging Software Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cancer Imaging Software Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cancer Imaging Software Revenue Market Share by Type (2021-2026) Table 30. Global Cancer Imaging Software Revenue Market Share by Type (2027-2032) Table 31. Global Cancer Imaging Software Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cancer Imaging Software Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cancer Imaging Software Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cancer Imaging Software Revenue Market Share by Application (2021-2026) Table 35. Global Cancer Imaging Software Revenue Market Share by Application (2027-2032) Table 36. Imaris Company Information Table 37. Imaris Business Overview Table 38. Imaris Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Imaris Cancer Imaging Software Product Portfolio Table 40. Imaris Recent Development Table 41. Varian Company Information Table 42. Varian Business Overview Table 43. Varian Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Varian Cancer Imaging Software Product Portfolio Table 45. Varian Recent Development Table 46. DOSIsoft Company Information Table 47. DOSIsoft Business Overview Table 48. DOSIsoft Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. DOSIsoft Cancer Imaging Software Product Portfolio Table 50. DOSIsoft Recent Development Table 51. Certis Oncology Company Information Table 52. Certis Oncology Business Overview Table 53. Certis Oncology Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Certis Oncology Cancer Imaging Software Product Portfolio Table 55. Certis Oncology Recent Development Table 56. MIM Software Inc. Company Information Table 57. MIM Software Inc. Business Overview Table 58. MIM Software Inc. Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. MIM Software Inc. Cancer Imaging Software Product Portfolio Table 60. MIM Software Inc. Recent Development Table 61. Arterys Company Information Table 62. Arterys Business Overview Table 63. Arterys Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Arterys Cancer Imaging Software Product Portfolio Table 65. Arterys Recent Development Table 66. SIEMENS Company Information Table 67. SIEMENS Business Overview Table 68. SIEMENS Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. SIEMENS Cancer Imaging Software Product Portfolio Table 70. SIEMENS Recent Development Table 71. Brainomix Company Information Table 72. Brainomix Business Overview Table 73. Brainomix Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Brainomix Cancer Imaging Software Product Portfolio Table 75. Brainomix Recent Development Table 76. Oncology Systems Limited Company Information Table 77. Oncology Systems Limited Business Overview Table 78. Oncology Systems Limited Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Oncology Systems Limited Cancer Imaging Software Product Portfolio Table 80. Oncology Systems Limited Recent Development Table 81. Mirada Company Information Table 82. Mirada Business Overview Table 83. Mirada Cancer Imaging Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Mirada Cancer Imaging Software Product Portfolio Table 85. Mirada Recent Development Table 86. GE HealthCare Company Information Table 87. GE HealthCare Business Overview Table 88. GE HealthCare Cancer Imaging Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. GE HealthCare Cancer Imaging Software Product Portfolio Table 90. GE HealthCare Recent Development Table 91. Mint Medical Company Information Table 92. Mint Medical Business Overview Table 93. Mint Medical Cancer Imaging Software Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Mint Medical Cancer Imaging Software Product Portfolio Table 95. Mint Medical Recent Development Table 96. North America Cancer Imaging Software Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Cancer Imaging Software Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Cancer Imaging Software Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Cancer Imaging Software Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Cancer Imaging Software Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Cancer Imaging Software Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Cancer Imaging Software Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Cancer Imaging Software Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Cancer Imaging Software Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Cancer Imaging Software Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Cancer Imaging Software Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Cancer Imaging Software Revenue by Country (US$ Million) & (2027-2032) Table 110. China Cancer Imaging Software Revenue by Type (2021-2026) & (US$ Million) Table 111. China Cancer Imaging Software Revenue by Type (2027-2032) & (US$ Million) Table 112. China Cancer Imaging Software Revenue by Application (2021-2026) & (US$ Million) Table 113. China Cancer Imaging Software Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Cancer Imaging Software Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Cancer Imaging Software Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Cancer Imaging Software Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Cancer Imaging Software Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Cancer Imaging Software Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Cancer Imaging Software Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Cancer Imaging Software Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Cancer Imaging Software Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Cancer Imaging Software Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Cancer Imaging Software Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Cancer Imaging Software Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Cancer Imaging Software Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Cancer Imaging Software Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Cancer Imaging Software Image Figure 2. Global Cancer Imaging Software Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Imaging Software Market Size Share 2021 VS 2025 VS 2032 Figure 4. CT Image Figure 5. MRI Image Figure 6. MRA Image Figure 7. Others Image Figure 8. Global Cancer Imaging Software Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Cancer Imaging Software Market Size Share 2021 VS 2025 VS 2032 Figure 10. Clinical Routine Image Figure 11. Clinical Trials Image Figure 12. Global Cancer Imaging Software Market Size (US$ Million) & (2021-2032) Figure 13. Global Cancer Imaging Software Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cancer Imaging Software Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cancer Imaging Software Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cancer Imaging Software Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cancer Imaging Software Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cancer Imaging Software Revenue Market Share by Type (2021-2032) Figure 20. Global Cancer Imaging Software Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cancer Imaging Software Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cancer Imaging Software Revenue Market Share by Application (2021-2032) Figure 23. North America Cancer Imaging Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cancer Imaging Software Revenue Share by Type (2021-2032) Figure 25. North America Cancer Imaging Software Revenue Share by Application (2021-2032) Figure 26. North America Cancer Imaging Software Revenue Share by Country (2021-2032) Figure 27. United States Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cancer Imaging Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cancer Imaging Software Revenue Share by Type (2021-2032) Figure 32. Europe Cancer Imaging Software Revenue Share by Application (2021-2032) Figure 33. Europe Cancer Imaging Software Revenue Share by Country (2021-2032) Figure 34. Germany Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cancer Imaging Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cancer Imaging Software Revenue Share by Type (2021-2032) Figure 44. China Cancer Imaging Software Revenue Share by Application (2021-2032) Figure 45. Asia Cancer Imaging Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cancer Imaging Software Revenue Share by Type (2021-2032) Figure 47. Asia Cancer Imaging Software Revenue Share by Application (2021-2032) Figure 48. Asia Cancer Imaging Software Revenue Share by Region (2021-2032) Figure 49. Japan Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cancer Imaging Software Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cancer Imaging Software Revenue Share by Type (2021-2032) Figure 57. SAMEA Cancer Imaging Software Revenue Share by Application (2021-2032) Figure 58. SAMEA Cancer Imaging Software Revenue Share by Country (2021-2032) Figure 59. Brazil Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cancer Imaging Software Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • CT
  • MRI
  • MRA
  • Others
Applications
  • Clinical Routine
  • Clinical Trials
Companies covered
  • Imaris
  • Varian
  • DOSIsoft
  • Certis Oncology
  • MIM Software Inc.
  • Arterys
  • SIEMENS
  • Brainomix
  • Oncology Systems Limited
  • Mirada
  • GE HealthCare
  • Mint Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cancer Imaging Software Market by Type
  3. 1.2.1 Global Cancer Imaging Software Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CT
  5. 1.2.3 MRI
  6. 1.2.4 MRA
  7. 1.2.5 Others
  8. 1.3 Cancer Imaging Software Market by Application
  9. 1.3.1 Global Cancer Imaging Software Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Clinical Routine
  11. 1.3.3 Clinical Trials
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cancer Imaging Software Market Dynamics
  1. 2.1 Cancer Imaging Software Industry Trends
  2. 2.2 Cancer Imaging Software Industry Drivers
  3. 2.3 Cancer Imaging Software Industry Opportunities and Challenges
  4. 2.4 Cancer Imaging Software Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cancer Imaging Software Market Perspective (2021-2032)
  2. 3.2 Global Cancer Imaging Software Growth Trends by Region
  3. 3.2.1 Global Cancer Imaging Software Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cancer Imaging Software Market Size by Region (2021-2026)
  5. 3.2.3 Global Cancer Imaging Software Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cancer Imaging Software Revenue by Players
  2. 4.1.1 Global Cancer Imaging Software Revenue by Players (2021-2026)
  3. 4.1.2 Global Cancer Imaging Software Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cancer Imaging Software Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cancer Imaging Software Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cancer Imaging Software Key Players Headquarters & Area Served
  7. 4.4 Global Cancer Imaging Software Players, Product Type & Application
  8. 4.5 Global Cancer Imaging Software Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cancer Imaging Software Market CR5 and HHI
  11. 4.6.3 2025 Cancer Imaging Software Tier 1, Tier 2, and Tier 3
5 Cancer Imaging Software Market Size by Type
  1. 5.1 Global Cancer Imaging Software Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cancer Imaging Software Revenue by Type (2021-2032)
  3. 5.3 Global Cancer Imaging Software Revenue Market Share by Type (2021-2032)
6 Cancer Imaging Software Market Size by Application
  1. 6.1 Global Cancer Imaging Software Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cancer Imaging Software Revenue by Application (2021-2032)
  3. 6.3 Global Cancer Imaging Software Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Imaris
  2. 7.1.1 Imaris Company Information
  3. 7.1.2 Imaris Business Overview
  4. 7.1.3 Imaris Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Imaris Cancer Imaging Software Product Portfolio
  6. 7.1.5 Imaris Recent Developments
  7. 7.2 Varian
  8. 7.2.1 Varian Company Information
  9. 7.2.2 Varian Business Overview
  10. 7.2.3 Varian Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Varian Cancer Imaging Software Product Portfolio
  12. 7.2.5 Varian Recent Developments
  13. 7.3 DOSIsoft
  14. 7.3.1 DOSIsoft Company Information
  15. 7.3.2 DOSIsoft Business Overview
  16. 7.3.3 DOSIsoft Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  17. 7.3.4 DOSIsoft Cancer Imaging Software Product Portfolio
  18. 7.3.5 DOSIsoft Recent Developments
  19. 7.4 Certis Oncology
  20. 7.4.1 Certis Oncology Company Information
  21. 7.4.2 Certis Oncology Business Overview
  22. 7.4.3 Certis Oncology Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Certis Oncology Cancer Imaging Software Product Portfolio
  24. 7.4.5 Certis Oncology Recent Developments
  25. 7.5 MIM Software Inc.
  26. 7.5.1 MIM Software Inc. Company Information
  27. 7.5.2 MIM Software Inc. Business Overview
  28. 7.5.3 MIM Software Inc. Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  29. 7.5.4 MIM Software Inc. Cancer Imaging Software Product Portfolio
  30. 7.5.5 MIM Software Inc. Recent Developments
  31. 7.6 Arterys
  32. 7.6.1 Arterys Company Information
  33. 7.6.2 Arterys Business Overview
  34. 7.6.3 Arterys Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Arterys Cancer Imaging Software Product Portfolio
  36. 7.6.5 Arterys Recent Developments
  37. 7.7 SIEMENS
  38. 7.7.1 SIEMENS Company Information
  39. 7.7.2 SIEMENS Business Overview
  40. 7.7.3 SIEMENS Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SIEMENS Cancer Imaging Software Product Portfolio
  42. 7.7.5 SIEMENS Recent Developments
  43. 7.8 Brainomix
  44. 7.8.1 Brainomix Company Information
  45. 7.8.2 Brainomix Business Overview
  46. 7.8.3 Brainomix Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Brainomix Cancer Imaging Software Product Portfolio
  48. 7.8.5 Brainomix Recent Developments
  49. 7.9 Oncology Systems Limited
  50. 7.9.1 Oncology Systems Limited Company Information
  51. 7.9.2 Oncology Systems Limited Business Overview
  52. 7.9.3 Oncology Systems Limited Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Oncology Systems Limited Cancer Imaging Software Product Portfolio
  54. 7.9.5 Oncology Systems Limited Recent Developments
  55. 7.10 Mirada
  56. 7.10.1 Mirada Company Information
  57. 7.10.2 Mirada Business Overview
  58. 7.10.3 Mirada Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Mirada Cancer Imaging Software Product Portfolio
  60. 7.10.5 Mirada Recent Developments
  61. 7.11 GE HealthCare
  62. 7.11.1 GE HealthCare Company Information
  63. 7.11.2 GE HealthCare Business Overview
  64. 7.11.3 GE HealthCare Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  65. 7.11.4 GE HealthCare Cancer Imaging Software Product Portfolio
  66. 7.11.5 GE HealthCare Recent Developments
  67. 7.12 Mint Medical
  68. 7.12.1 Mint Medical Company Information
  69. 7.12.2 Mint Medical Business Overview
  70. 7.12.3 Mint Medical Cancer Imaging Software Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Mint Medical Cancer Imaging Software Product Portfolio
  72. 7.12.5 Mint Medical Recent Developments
8 North America
  1. 8.1 North America Cancer Imaging Software Revenue (2021-2032)
  2. 8.2 North America Cancer Imaging Software Revenue by Type (2021-2032)
  3. 8.2.1 North America Cancer Imaging Software Revenue by Type (2021-2026)
  4. 8.2.2 North America Cancer Imaging Software Revenue by Type (2027-2032)
  5. 8.3 North America Cancer Imaging Software Revenue Share by Type (2021-2032)
  6. 8.4 North America Cancer Imaging Software Revenue by Application (2021-2032)
  7. 8.4.1 North America Cancer Imaging Software Revenue by Application (2021-2026)
  8. 8.4.2 North America Cancer Imaging Software Revenue by Application (2027-2032)
  9. 8.5 North America Cancer Imaging Software Revenue Share by Application (2021-2032)
  10. 8.6 North America Cancer Imaging Software Revenue by Country
  11. 8.6.1 North America Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cancer Imaging Software Revenue by Country (2021-2026)
  13. 8.6.3 North America Cancer Imaging Software Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cancer Imaging Software Revenue (2021-2032)
  2. 9.2 Europe Cancer Imaging Software Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cancer Imaging Software Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cancer Imaging Software Revenue by Type (2027-2032)
  5. 9.3 Europe Cancer Imaging Software Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cancer Imaging Software Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cancer Imaging Software Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cancer Imaging Software Revenue by Application (2027-2032)
  9. 9.5 Europe Cancer Imaging Software Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cancer Imaging Software Revenue by Country
  11. 9.6.1 Europe Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cancer Imaging Software Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cancer Imaging Software Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cancer Imaging Software Revenue (2021-2032)
  2. 10.2 China Cancer Imaging Software Revenue by Type (2021-2032)
  3. 10.2.1 China Cancer Imaging Software Revenue by Type (2021-2026)
  4. 10.2.2 China Cancer Imaging Software Revenue by Type (2027-2032)
  5. 10.3 China Cancer Imaging Software Revenue Share by Type (2021-2032)
  6. 10.4 China Cancer Imaging Software Revenue by Application (2021-2032)
  7. 10.4.1 China Cancer Imaging Software Revenue by Application (2021-2026)
  8. 10.4.2 China Cancer Imaging Software Revenue by Application (2027-2032)
  9. 10.5 China Cancer Imaging Software Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cancer Imaging Software Revenue (2021-2032)
  2. 11.2 Asia Cancer Imaging Software Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cancer Imaging Software Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cancer Imaging Software Revenue by Type (2027-2032)
  5. 11.3 Asia Cancer Imaging Software Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cancer Imaging Software Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cancer Imaging Software Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cancer Imaging Software Revenue by Application (2027-2032)
  9. 11.5 Asia Cancer Imaging Software Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cancer Imaging Software Revenue by Country
  11. 11.6.1 Asia Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cancer Imaging Software Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cancer Imaging Software Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cancer Imaging Software Revenue (2021-2032)
  2. 12.2 SAMEA Cancer Imaging Software Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cancer Imaging Software Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cancer Imaging Software Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cancer Imaging Software Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cancer Imaging Software Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cancer Imaging Software Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cancer Imaging Software Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cancer Imaging Software Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cancer Imaging Software Revenue by Country
  11. 12.6.1 SAMEA Cancer Imaging Software Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cancer Imaging Software Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cancer Imaging Software Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst